FOXC2 is a prognostic biomarker and contributes to the growth and invasion of human hepatocellular carcinomaJinzhang Chen(Nanfang Hospital), Jian Ruan(TCM-Intigrated Cancer Center of Southern Medical University)Cancer Cell InternationalMay 26, 202010.1186/s12935-020-01265-0Cited by 12SaveCiteExport RISWatch citationsRelated PapersModulation of the tumour microenvironment in hepatocellular carcinoma by tyrosine kinase inhibitors: from modulation to combination therapy targeting the microenvironment|Cancer Cell International|2022|47